Podcasts about horizon pharma

Stephen Drum is a retired combat-tested Navy SEAL Master Chief who has 27 years of experience leading and developing high-performance teams.  As a speaker and consultant, he helps individuals and organizations such as CDW, Horizon Pharma, and 9 Energy develop leadership and performance strategies, so they can plan, prepare, and execute at the highest levels when it matters most. Find his website here! https://stephendrum.com/

The Lazy CEO Podcast guest on this episode is Stephen Drum. Stephen is a 27-year, Navy Seal retired combat vet and he now speaks on leadership, some of the lessons that they learned and developed through his many years of leading people through dangerous, high-stress, mission-critical, environments, which we can all learn a lot from as we run our business. Here is a little bit of the conversation between Jim Schleckser, CEO of The CEO Project, and Stephen Drum. Jim: What is warrior toughness? How do you measure it? As CEOs we would really like to figure out when we hire somebody when the fire starts, are they going to run to the fire or away from the fire? What is toughness? Stephen: Well, to set the scene quickly, I'm sitting there, and we have what's called an all-hands call. That's where the whole entire command will sit and either the commander or somebody from outside will come in. So we're doing an all-hands call in the chapel, which is the biggest place where everybody can all sit. And the chief of naval operations, who is the head admiral of the Navy, comes in and starts talking about his initiatives. And one of them was toughness. I have the bright idea to stand up and say, sir, how do we define toughness? How are we going to measure it? And how are we actually going to train it? Little did I know that about six months later, I would be locked in a room with a clinical psychologist, and a chaplain and the three of us would be charged with figuring out how to get our sailors tough. There were some things in the fleet that hadn't really been going well. If you think of like the fighting sailors from World War ii, we kind of lost that. And now we have things going on, ships colliding, missiles being fired; we need tougher sailors. And so of course, the first thing was we had to define what it is. And so, we defined toughness in three areas. First, you have to take a punch and keep on going. There's the tactical definition, but also the life definition. So, literally, we're on a ship, friends wounded, comrades are injured, and I have to get back up. I may be personally injured myself and I must get back in the fight. But it also takes a punch in my career. I didn't get that promotion. Maybe a loss of a relationship or loss of a loved one, but I have to get up and move forward. Next, I must perform under pressure, in the clutch. It's one thing to know the skills to say, I've been trained, I've practiced, but can you perform under pressure? Can you regulate those emotions? Can you maintain your calm and your composure? And lastly, the day-in, day-out grind. And that swings both ways. That's a high-tempo operation that we would see in the seal teams, multiple combat operations a night for six months. The grind and the toll that takes both physically, emotionally, and mentally. But then also the other side of that coin, let's say a radar operator on a destroyer in the middle of the ocean, at the end of that six-month deployment, staring at a screen. 99.9% of the time, nothing happens, but people are going die if that person is not locked on in case something does. So, it's having that attention and commitment to that level of engagement for a long, protracted period. Finally, having the fundamental values, and beliefs, and knowing how to take action and behave in a way through principles that support those values and beliefs. Because not only do we need people that recognize this, therefore they can arrive at a higher level of commitment to what we need them to do. But we need our sailors, our warfighters, to be people of character. It's one thing, to accomplish the tactical objective, but we need people to be people of the right character to make good moral and ethical decisions as well. Jim: Can everybody get there? I'll give you an example. I was on a board of a company and, and we had some tough times, like missing numbers, bank covenant violation. The bank was ready to take the keys to the building. It was interesting to watch the performance of the executive team. Some ran toward, like we call it, ran towards the fire, right? They said, how can I help? What can I do? Let me take something on, let me right others. Can everybody be brought to the point that they would run to the fire? Are they born or can they be made? And I always default to decide that yes, people are more predisposed to have certain traits, characteristics and attributes to make them more gregarious, whatever that is. But ultimately, I believe that we can build that even if you tend to be an introvert, you can still do things. For example, I refuse to believe that somebody who's introverted can't go out and be a good sales rep. Stephen: I also believe that you can always be tougher. There must be a level of commitment that says this is important, and I'm going to do everything possible for me to set the table for my success, and for my team's success. You can do your very best, but if you at the end of the day cannot be bought into that concept, then I'm going to have to exit you from my sphere. Jim: And that does happen. We talked about how this applies to the business environment. You could argue the stakes aren't quite as high, but the ideas certainly translate. How do you translate that line of thinking to a business environment and give an example or two of how you've seen it work? Stephen: The concept that I talk about is the X and I think it's important. My book is called Life on the X, but the X goes back to my time in the military. And it's a military doctrine term, but you can think of it as X marks the spot. So if you rope out of a helicopter onto the rooftop of a building, we call that landing on the X. I'm going to line up all my efforts and all my preparations to make sure that I show up, that I can handle curve balls, that I can pivot, that I can adjust, and that I can learn. Every engagement that you make, you must be intentional, whether it's internal to your organization, to your customer, or to your partner. I must make sure that I align the skills, I identify the gaps in my performance so that when I walk in there, I'm calm and composed, but I also have that level of, okay, I'm hovering above, I can make a decision. I'm not too close to the problem. So really it's about regulating your emotions. For more of the conversation between Jim and Steven, listen to the full Podcast. Thank you to our guest... Stephen Drum is a combat-tested retired Navy SEAL Master Chief who has 27 years of experience leading and developing high-performance teams. As an in-demand speaker and consultant, he helps individuals and organizations such as CDW, Horizon Pharma, and 9 Energy develop leadership and performance strategies, so they can plan, prepare, and execute at the highest levels when it matters most. Steve has trained and led U.S. and foreign partner special operations forces on high-risk and strategically vital missions across the globe, including combat operations in rag and Afghanistan. He recently co-developed and taught "Warrior Toughness" training for The U.S. Navy. This vital program fundamentally changed the culture of the Navy in how it trains and prepares young sailors and officers for the acute stress of intense combat operations. During his Navy career, Steve has personally trained thousands of elite military soldiers and Navy SEAL candidates, helping them succeed in severe training courses and overseas combat operations.

Description: In 2021, a work group of international experts published an update to the 2012 iteration of this guideline. To do so they reviewed the latest evidence through a systematic literature review, with the aim of providing a useful resource for clinicians caring for individuals with glomerular disease through actionable recommendations. In this episode we speak to Dr Richard Glassock, member of the work group, to hear his insights on the key takeaways from the guideline, and what has changed in this iteration. By completing this activity you can qualify for 0.25 CME credits. To claim your credits, you must listen to the podcast and successfully pass the post-module assessment at nephrology.knowledgeintopractice.com, where you can find all past episodes of the podcast as well as other free CME resources. Reference: KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int 2021;100(4S):S1–S276. Disclosures: Dr Richard Glassock declares the following: Stock Ownership - Reata Pharmaceuticals Speakers Bureau - Aurinia Advisory Board - Alexion, Bio-Cryst, Novartis, Otsuka, RenaSight, Travere, Vertex Consultant - Alexion, Arrowhead, Aurinia, Bio-Cryst, Calliditas, Chinook, Equillium, Horizon Pharma, Ionis, Midornid, Nephro-Sys, Omeros, River3Renal, Therini Bio, Travere, Vera Pharmaceuticals Liberum IME staff, ACHL staff and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose. The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships within 24 months (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any ineligible companies. All relevant financial relationships have been mitigated prior to this activity. The content for this series was developed independently of the ineligible companies. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantors. This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis. Discussion of Off-Label, Investigational or Experimental Drug Use: Corticosteroids are mentioned in the context of the treatment of FSGS. Funding: This independent educational activity is supported by an educational grant from Travere Therapeutics. The educational content has been developed by Liberum IME in conjunction with an independent steering committee; Travere Therapeutics has had no influence on the content of this education.

Stephen Drum is a combat-tested retired Navy SEAL Master Chief who has 27 years of experience leading and developing high-performance teams. As an in-demand speaker and consultant, he helps individuals and organizations such as CDW, Horizon Pharma, and 9 Energy develop leadership and performance strategies, so they can plan, prepare, and execute at the highest levels when it matters most. Stephen has trained and led U.S. and foreign partner special operations forces on high-risk and strategically vital missions across the globe, including combat operations in Iraq and Afghanistan. He recently co- developed and taught “Warrior Toughness” - training for The U.S. Navy. This vital program fundamentally changed the culture of the Navy in how it trains and prepares young sailors and officers for the acute stress of intense combat operations. During his Navy career, Stephen has personally trained thousands of elite military soldiers and Navy SEAL candidates, helping them succeed in severe training courses and overseas combat operations. Now he takes that experience and uses it to help everyday people apply it in their everyday lives, while they face their most challenging missions each and every day. NEXT STEPS MENTIONED IN THIS VIDEO: 1. Go to stephendrum.com. 2. Message him at steve@stephendrum.com. TOPICS DISCUSSED IN THIS VIDEO: [0:25] – High Performance Identity Traits. [1:52] – What Works to Take it to the Next Level? [3:25] – Common Tools for Focus. [4:18] – Warrior Toughness. [7:39] – Tripod – Three-Legged Stool. [9:11] – What Made You Gravitate Toward Navy Seals? [10:32] – Master Chief Translate Into Business World. [13:55] – Platoons Coming In – Can You Predict Who Will Pass? [16:48] – Paying the Price. [19:55] – Developing, Shaping, and Creating Leadership. [23:56] – Mentors. [27:17] – Traits to Be Remembered By. [29:45] – Leading with Humility. [34:44] – Gifts of Wisdom.

Today's guest is a retired Navy SEAL Master Chief with 27 years of experience leading and developing high-performance teams. As an influential speaker and consultant, he helps companies like CDW, Horizon Pharma, and 9 Energy develop leadership strategies so they can make the most of any given event. Stephen trained and led U.S. and foreign partner special operations forces on high-risk, strategically vital missions across the globe, including combat actions in Iraq and Afghanistan. He recently co-developed and taught "Warrior Toughness" training for the Navy. This program fundamentally changed the culture of service in how it trains and prepares the nation's finest to cope with combat missions. During his Navy career, Stephen trained thousands of elite military soldiers and Navy SEAL candidates. Which makes him qualified to speak to the confidence challenges that come with military service. Stephen has a long-time commitment to strengthening our country's national security by helping officers, sailors, Marines, and SEALs become better leaders so they can protect us all from harm. You have to hear this story. So please, help me welcome to We Do Hard Things - Steve Drum Hey there, I'm Mark Drager. You may not know me (yet) but:

@schedulicity and @hairdustry presents Your Day Off podcast- Stephen Drum @stephen.drum- is a combat-tested retired Navy SEAL Master Chief who has 27 years of experience leading and developing high-performance teams. As a speaker and consultant, he helps individuals and organizations such as CDW, Horizon Pharma, and 9 Energy develop leadership and performance strategies, so they can plan, prepare, and execute at the highest levels when it matters most. --- Support this podcast: https://anchor.fm/hairdustry/support

18. Warrior Toughness, Preparation and Purpose: Acts of Service"When morale seems to dip in organizations and you start to face that doubt, when you start to feel disillusionment set in, a lot of the times, it’s because you start to lose that sense of purpose.” Guest Info:Stephen Drum is a combat-tested retired Navy SEAL Master Chief who has 27 years of experience leading and developing high-performance teams. As an in-demand speaker and consultant, he helps individuals and organizations such as CDW, Horizon Pharma, and 9 Energy develop leadership and performance strategies, so they can plan, prepare, and execute at the highest levels when it matters most.Stephen has trained and led U.S. and foreign partner special operations forces on high-risk and strategically vital missions across the globe, including combat operations in Iraq and Afghanistan.He recently co-developed and taught “Warrior Toughness” training for the U.S. Navy. This vital program fundamentally changed the culture of the Navy in how it trains and prepares young sailors and officers for the acute stress of intense combat operations.During his Navy career, Stephen has personally trained thousands of elite military soldiers and Navy SEAL candidates, helping them succeed in severe training courses and overseas combat operations.Favorite Quote:"When it comes to business: I am a professional, I don't crumble when things get hard, I exist to be of service."Resources:Stephen Drum on LinkedInBreaching LeadershipHeroic Public SpeakingShannon Cassidy on YouTubeFor more information about R.O.G. Return on Generosity and host Shannon Cassidy, visit bridgebetween.com.Credits:Stephen Drum. Production team: Nani Shin, Sheep Jam Productions, qodpod

Stephen Drum is a combat-tested retired Navy SEAL Master Chief who has 27 years of experience leading and developing high-performance teams. As an in-demand speaker and consultant, he helps individuals and organizations such as CDW, Horizon Pharma, and 9 Energy develop leadership and performance strategies, so they can plan, prepare, and execute at the highest levels when it matters most. Stephen has trained and led U.S. and foreign partner special operations forces on high-risk and strategically vital missions across the globe, including combat operations in Iraq and Afghanistan.

Stephen Drum is a retired combat-tested Navy SEAL Master Chief who has 27 years of experience leading and developing high-performance teams. As a speaker and consultant, he helps individuals and organizations such as CDW, Horizon Pharma, and 9 Energy develop leadership and performance strategies, so they can plan, prepare, and execute at the highest levels when it matters most.  Join us for a talk about what he found most important to succeeding no matter where he was: leaning into the relationships around you.

Horizon Therapeutics (в прошлом году изменила название, прежнее — Horizon Pharma) — базирующаяся в Дублине биофармацевтическая компания, которая специализируется преимущественно на препаратах от редких заболеваний. Акции Horizon Therapeutics за последний год принесли доходность 55,9%, значительно опережающую показатели американского рынка в целом. Мы обращаем внимание на важное событие января — FDA одобрило новый препарат компании teprotumumab, с которым во многом были связаны наши оптимистичные инвестиционные ожидания. На основании этого мы по-прежнему считаем акции компании привлекательными для вложений.

Tune in for a very special edition of the show called Talking to Cool People: After Dark. It's the same show you know and love...recorded at night with drinks in our hands!Steve shares some incredible lessons from his 25 years serving around the world as a Navy Seal, how he almost didn't get a chance to do that because of some damn math problems, and Steve is generous with his recommendations for me and the audience for high quality and reasonably priced bourbon.Stephen Drum is a combat-tested retired Navy SEAL Master Chief who has 27 years of experience leading and developing high-performance teams.As an in-demand speaker and consultant, he helps individuals and organizations such as CDW, Horizon Pharma, and 9 Energy develop leadership and performance strategies, so they can plan, prepare, and execute at the highest levels when it matters most.Stephen has trained and led U.S. and foreign partner special operations forces on high-risk and strategically vital missions across the globe, including combat operations in Iraq and Afghanistan.He recently co-developed and taught “Warrior Toughness” training for the U.S. Navy. This vital program fundamentally changed the culture of the Navy in how it trains and prepares young sailors and officers for the acute stress of intense combat operations.During his Navy career, Stephen has personally trained thousands of elite military soldiers and Navy SEAL candidates, helping them succeed in severe training courses and overseas combat operations.https://www.facebook.com/stephen.drum.967http://linkedin.com/in/stephen-drum-643695135http://instagram.com/Stephen.drumLove the podcast? Please tell your friends, give us a shoutout and a follow on social media, or take a moment to leave us a review on iTunes or wherever else you get your shows!Find the show at all of the cool spots below.WebsiteFacebookInstagramYoutubeIf something from this or any episode has sparked your interest and you’d like to connect about it, please email us at podcast@jasonfrazell.com. We love hearing from our listeners!If you are interested in being a guest on the show, please visit jasonfrazell.com/podcast and click on the “Learn More” button at the bottom of the page.Artwork by Jordan Snodgrass

Horizon Therapeutics (в мае изменила название, прежнее - Horizon Pharma) – базирующаяся в Дублине биофармацевтическая компания, специализирующаяся преимущественно на препаратах от редких заболеваний. Мы по-прежнему считаем акции компании привлекательными для вложений, при этом потенциал их роста на ближайшие 12 месяцев может составить 18%. Мы сохраняем по акциям Horizon Therapeutics рекомендацию «Покупать».

In this episode Sean Costella takes us through the events leading up to his diagnosis of a rare disease, a cavernoma, and how he took a leap of faith on one doctor's opinion that ended up saving his life. When his symptoms got so bad that they couldn't be ignored, Sean underwent an emergency surgery. Luckily, that surgery went well, but when he woke up he couldn't see. After a long, and very difficult, recovery, Sean has returned to a pretty normal life. Through this experience he's grown to appreciate the simple things in life that we often take for granted. Sean is especially grateful for his wife, who not only helped him through months of rehabilitative therapy, she also did this while taking care of their newly born first daughter. He now brings this newfound perspective into his work as a territory manager at Horizon Pharma, a company that focuses on rare disease medicines, where he connects with physicians and patients on a personal level. Sean's positivity is admirable. If you'd like to learn more about the disease you can visit the Angioma Alliance at www.angioma.org or on Facebook. You can also connect with Sean at seancostella333@gmail.com if you want to learn more from his experience.

Patients as Partners Day 2 Session How FARA and Horizon Pharma Partnered to Improve Clinical Development and Trial Design-Case Study This session will feature how the Friedreich’s Ataxia Research Foundation collaborated with Horizon Pharma on aspects of clinical development and trial design to better understand patients living with the disease and how to better develop medicine to help manage their disease. Key areas of discussion include how they collaborated on the following: • Focus groups to better understand drug administration • Clinical trial design to ensure feasibility and efficiency • Recruiting patients for clinical trials • Open discussion at FDA meetings Kyle Bryant Director of the Bicycle Ride Fundraiser, rideAtaxia for the Friedreich’s Ataxia Research Alliance (FARA)  Robert Metz SVP, Global Business Operations and External Affairs, Horizon Pharma

Join us for a discussion about patient engagement in rare diseases with Horizon Pharma.  This is our first recording in front of a live audience!

Join us for a discussion about rare disease patient engagement recorded LIVE at Horizon Pharma.

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: Sanofi, Allergan, Novartis, Uniqure, Horizon Pharma, Biogen, Recordati, Alexion Pharmaceuticals, AIFA, EMA, Diasorin, Kedrion Biopharma.Persone: David Nicholson (Allergan), Pierluigi Petrone (Global Virus Network), Massimo Galli (SIMIT), Sandra Horning (Roche), Riccardo Perfetti (Sanofi), Alessandro Segato (Aip), Carlo Agostini (Ospedale di Padova).Nuove terapie: emicizumab, insulina glargine.Patologie: Steatoepatite non alcolica, deficit familiare di lipoproteina lipasi, disordini del ciclo dell’urea, atrofia muscolare spinale, Malattia di Pompe, malattia granulomatosa cronica, osteopetrosi maligna severa, emoglobinuria parossistica notturna, Sindrome emolitico-uremica atipica, carcinoma uterino, emofilia A, diabete, immunodeficienze primitive.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/

PharmaPills - Pillole dal farmaceutico: Novità, Curiosità e Lavoro dal mondo del farmaceutico. A cura di Stefano LagravineseIn questa puntata parliamo di:Aziende: Sanofi, Allergan, Novartis, Uniqure, Horizon Pharma, Biogen, Recordati, Alexion Pharmaceuticals, AIFA, EMA, Diasorin, Kedrion Biopharma.Persone: David Nicholson (Allergan), Pierluigi Petrone (Global Virus Network), Massimo Galli (SIMIT), Sandra Horning (Roche), Riccardo Perfetti (Sanofi), Alessandro Segato (Aip), Carlo Agostini (Ospedale di Padova).Nuove terapie: emicizumab, insulina glargine.Patologie: Steatoepatite non alcolica, deficit familiare di lipoproteina lipasi, disordini del ciclo dell’urea, atrofia muscolare spinale, Malattia di Pompe, malattia granulomatosa cronica, osteopetrosi maligna severa, emoglobinuria parossistica notturna, Sindrome emolitico-uremica atipica, carcinoma uterino, emofilia A, diabete, immunodeficienze primitive.Ogni mercoledì alle h 12.00 su Spreaker.com e iTunes.Seguici su: www.telegram.me/pharmapillswww.facebook.com/pharmapills/

Today in FirstWord:

Today in FirstWord:

Today in FirstWord:

Today in FirstWord:

Today in FirstWord:

Today in FirstWord:

Today in FirstWord:

Today in FirstWord:

Today in FirstWord:

Today in FirstWord:

Today in FirstWord:

Option Block 165: I Make Liquidity Trading Block: Another day, another mild selloff. VIX getting the weekend/holiday back, plus a little more. Oil/Commodity rundown - the hot, dry weather has had a big impact of the ags, especially corn. Activision on the block. Odd Block: An unusual activity review for Materials Select Sector SPDR (XLB), Research in Motion, Ltd. (RIMM), and Horizon Pharma, Inc. HZNP (HZNP). Xpress Block: John Grigus gets the floor over at the OX desk and discuss the recent grain market and what to remember if you want to start trading ag futures and options. Mail Block: Option Block, I wanted to know what way you found is the best to explain to common folk that you trade options for living -- I find it very difficult to answer the common question of "what do you do for a living?". Even my most successful attempts I am always met with rather blank stares -- or worse if they have a sliver of knowledge they think that I just buy low and sell high common stock which I think most options traders find unsophisticatedly insulting. Please help me with your infinite wisdom. (Via the Options Insider forum by: optionsvoodoo) Around the Block: Earnings season is back! Google on July 12, Citi on the 16th. Apple running pre pre-earnings. Keeping an eye on Activision and EA.